These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32739192)

  • 1. Chloramphenicol Eye Drops: An Old Dog in a New House.
    Andaluz-Scher L; Medow NB
    Ophthalmology; 2020 Oct; 127(10):1289-1291. PubMed ID: 32739192
    [No Abstract]   [Full Text] [Related]  

  • 2. Seeing red: over-the-counter chloramphenicol.
    Robaei D; Naunton M; Watson S
    Clin Exp Ophthalmol; 2015 Mar; 43(2):99-100. PubMed ID: 25833086
    [No Abstract]   [Full Text] [Related]  

  • 3. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops.
    Fukuda M; Ohashi H; Matsumoto C; Mishima S; Shimomura Y
    Cornea; 2002 Oct; 21(7 Suppl):S86-9. PubMed ID: 12484705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjunctivitis in children.
    Normann EK
    Lancet; 2005 Jul 2-8; 366(9479):6-7. PubMed ID: 15993210
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of efficacy and safety of ciprofloxacin ophthalmic solution versus chloramphenicol.
    Power WJ; Collum LM; Easty DL; Bloom PA; Laidlaw DA; Libert J; Sangers D; Wuokko M; Saksela T
    Eur J Ophthalmol; 1993; 3(2):77-82. PubMed ID: 8353434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of Bacterial Conjunctivitis in Children-Preferred Practice Pattern in Northern Greece.
    Mataftsi A; Kokkali S; Papagianni E; Tsonona V; Mavridou E; Ziakas N; Haidich AB
    Eye Contact Lens; 2018 Sep; 44 Suppl 1():S373-S374. PubMed ID: 30157160
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of acute neonatal bacterial conjunctivitis: a comparison of fucidic acid to chloramphenicol eye drops.
    Normann EK; Bakken O; Peltola J; Andréasson B; Buhl S; Sigg P; Nielsen K
    Acta Ophthalmol Scand; 2002 Apr; 80(2):183-7. PubMed ID: 11952486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial.
    Rose PW; Harnden A; Brueggemann AB; Perera R; Sheikh A; Crook D; Mant D
    Lancet; 2005 Jul 2-8; 366(9479):37-43. PubMed ID: 15993231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigations on chloramphenicol availability in ophthalmic lamellae].
    Gafitanu E; Zvorişteanu V; Matei I; Braha S; Dorneanu V; Awe B
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(3):519-23. PubMed ID: 16296483
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical administration of chloramphenicol can induce acute hepatitis.
    Doshi B; Sarkar S
    BMJ; 2009 Jun; 338():b1699. PubMed ID: 19525305
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of acute infective conjunctivitis.
    Drug and Therapeutics Bulletin
    Drug Ther Bull; 2011 Jul; 49(7):78-81. PubMed ID: 21733975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chloramphenicol eyedrops in acute bacterial conjunctivitis].
    Sandvig KU
    Tidsskr Nor Laegeforen; 1994 Apr; 114(9):1104. PubMed ID: 8009528
    [No Abstract]   [Full Text] [Related]  

  • 13. Topical chloramphenicol for eye infections.
    Lam RF; Lai JS; Ng JS; Rao SK; Law RW; Lam DS
    Hong Kong Med J; 2002 Feb; 8(1):44-7. PubMed ID: 11861993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute conjunctivitis. A comparison of fusidic acid viscous eye drops and chloramphenicol.
    Hørven I
    Acta Ophthalmol (Copenh); 1993 Apr; 71(2):165-8. PubMed ID: 8333258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of azithromycin 1.5% eye drops in paediatric population with purulent bacterial conjunctivitis.
    Bremond-Gignac D; Nezzar H; Bianchi PE; Messaoud R; Lazreg S; Voinea L; Speeg-Schatz C; Hartani D; Kaercher T; Kocyla-Karczmarewicz B; Murta J; Delval L; Renault D; Chiambaretta F;
    Br J Ophthalmol; 2014 Jun; 98(6):739-45. PubMed ID: 24526744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. It is time to stop using topical chloramphenicol.
    Smith JR; Wesselingh S; Coster DJ
    Aust N Z J Ophthalmol; 1997 Feb; 25(1):83-8. PubMed ID: 9107404
    [No Abstract]   [Full Text] [Related]  

  • 17. Preparation and characterization of chloramphenicol niosomes and comparison with chloramphenicol eye drops (0.5%w/v) in experimental conjunctivitis in albino rabbits.
    Yasin MN; Hussain S; Malik F; Hameed A; Sultan T; Qureshi F; Riaz H; Perveen G; Wajid A
    Pak J Pharm Sci; 2012 Jan; 25(1):117-21. PubMed ID: 22186318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restricting topical ocular chloramphenicol eye drop use in the United States. Did we overreact?
    Fraunfelder FW; Fraunfelder FT
    Am J Ophthalmol; 2013 Sep; 156(3):420-422. PubMed ID: 23953152
    [No Abstract]   [Full Text] [Related]  

  • 19. The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970-2000.
    Baum J; Barza M
    Cornea; 2000 Sep; 19(5):659-72. PubMed ID: 11009318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel case of chronic conjunctivitis in a 58-year-old woman caused by Raoultella.
    Zuberbuhler B; Abedin A; Roudsari A
    Infection; 2014 Oct; 42(5):927-9. PubMed ID: 24865691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.